HCM
ARNA

Highbridge Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Highbridge Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,000
Closed -$593K – 1438
2018
Q1 		$593K Buy
+15,000
New +$583K 0.01% 644

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Highbridge Capital Management's ARNA Position: Q1 2015 in Review

Highbridge Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2015, closing a stake of 3,755 shares — an estimated $131K sold.

Highbridge Capital Management first reported a position in ARNA in Q3 2013 and held it in 2 quarters. The position peaked at $1.97M in Q3 2013. 122 funds tracked by Wall St. Rank hold ARNA as of Q1 2015.

  • Highbridge Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Highbridge Capital Management sold 3,755 Arena Pharmaceuticals Inc shares in Q1 2015, an estimated $131K.
  • Highbridge Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 2 quarters.
  • Highbridge Capital Management's Arena Pharmaceuticals Inc position peaked at $1.97M in Q3 2013.
  • 122 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2015.

Based on Highbridge Capital Management's 13F filing for Q1 2015, filed 15 May 2015.